Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma

Multiple myeloma, a typical hematological malignancy, is characterized by malignant proliferation of plasma cells. This study was to identify differently expressed long non-coding RNAs to predict the survival of patients with multiple myeloma efficiently. Gene expressing profiles of diagnosed patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Ai-Xin Hu, Zhi-Yong Huang, Lin Zhang, Jian Shen
Format: Article
Language:English
Published: SAGE Publishing 2017-04-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317694563
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850053688624676864
author Ai-Xin Hu
Zhi-Yong Huang
Lin Zhang
Jian Shen
author_facet Ai-Xin Hu
Zhi-Yong Huang
Lin Zhang
Jian Shen
author_sort Ai-Xin Hu
collection DOAJ
description Multiple myeloma, a typical hematological malignancy, is characterized by malignant proliferation of plasma cells. This study was to identify differently expressed long non-coding RNAs to predict the survival of patients with multiple myeloma efficiently. Gene expressing profiles of diagnosed patients with multiple myeloma, GSE24080 (559 samples) and GSE57317 (55 samples), were downloaded from Gene Expression Omnibus database. After processing, survival-related long non-coding RNAs were identified by Cox regression analysis. The prognosis of multiple myeloma patients with differently expressed long non-coding RNAs was predicted by Kaplan–Meier analysis. Meanwhile, stratified analysis was performed based on the concentrations of serum beta 2-microglobulin (S-beta 2m), albumin, and lactate dehydrogenase of multiple myeloma patients. Gene set enrichment analysis was performed to further explore the functions of identified long non-coding RNAs. A total of 176 long non-coding RNAs significantly related to the survival of multiple myeloma patients (p < 0.05) were identified. In dataset GSE24080 and GSE57317, there were 558 and 55 patients being clustered into two groups with significant differences, respectively. Stratified analysis indicated that prediction of the prognoses with these long non-coding RNAs was independent from other clinical phenotype of multiple myeloma. Gene set enrichment analysis–identified pathways of cell cycle, focal adhesion, and G2-M checkpoint were associated with these long non-coding RNAs. A total of 176 long non-coding RNAs, especially RP1-286D6.1, AC008875.2, MTMR9L, AC069360.2, and AL512791.1, were potential biomarkers to evaluate the prognosis of multiple myeloma patients. These long non-coding RNAs participated indispensably in many pathways associated to the development of multiple myeloma; however, the molecular mechanisms need to be further studied.
format Article
id doaj-art-9679d69e09424c7aaec3e18961574794
institution DOAJ
issn 1423-0380
language English
publishDate 2017-04-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-9679d69e09424c7aaec3e189615747942025-08-20T02:52:27ZengSAGE PublishingTumor Biology1423-03802017-04-013910.1177/1010428317694563Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myelomaAi-Xin Hu0Zhi-Yong Huang1Lin Zhang2Jian Shen3Department of Orthopedic Surgery, People’s Hospital of Three Gorges University, Yichang, ChinaPuAi Institute, Edong Healthcare Group, Huangshi Central Hospital, Huangshi, ChinaDepartment of Spinal Surgery, The Affiliated Huai’an Hospital of Xuzhou Medical University and The Second People’s Hospital of Huai’an, Huai’an, ChinaChangzhou Hygiene Vocational Technology School, Changzhou, ChinaMultiple myeloma, a typical hematological malignancy, is characterized by malignant proliferation of plasma cells. This study was to identify differently expressed long non-coding RNAs to predict the survival of patients with multiple myeloma efficiently. Gene expressing profiles of diagnosed patients with multiple myeloma, GSE24080 (559 samples) and GSE57317 (55 samples), were downloaded from Gene Expression Omnibus database. After processing, survival-related long non-coding RNAs were identified by Cox regression analysis. The prognosis of multiple myeloma patients with differently expressed long non-coding RNAs was predicted by Kaplan–Meier analysis. Meanwhile, stratified analysis was performed based on the concentrations of serum beta 2-microglobulin (S-beta 2m), albumin, and lactate dehydrogenase of multiple myeloma patients. Gene set enrichment analysis was performed to further explore the functions of identified long non-coding RNAs. A total of 176 long non-coding RNAs significantly related to the survival of multiple myeloma patients (p < 0.05) were identified. In dataset GSE24080 and GSE57317, there were 558 and 55 patients being clustered into two groups with significant differences, respectively. Stratified analysis indicated that prediction of the prognoses with these long non-coding RNAs was independent from other clinical phenotype of multiple myeloma. Gene set enrichment analysis–identified pathways of cell cycle, focal adhesion, and G2-M checkpoint were associated with these long non-coding RNAs. A total of 176 long non-coding RNAs, especially RP1-286D6.1, AC008875.2, MTMR9L, AC069360.2, and AL512791.1, were potential biomarkers to evaluate the prognosis of multiple myeloma patients. These long non-coding RNAs participated indispensably in many pathways associated to the development of multiple myeloma; however, the molecular mechanisms need to be further studied.https://doi.org/10.1177/1010428317694563
spellingShingle Ai-Xin Hu
Zhi-Yong Huang
Lin Zhang
Jian Shen
Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma
Tumor Biology
title Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma
title_full Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma
title_fullStr Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma
title_full_unstemmed Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma
title_short Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma
title_sort potential prognostic long non coding rna identification and their validation in predicting survival of patients with multiple myeloma
url https://doi.org/10.1177/1010428317694563
work_keys_str_mv AT aixinhu potentialprognosticlongnoncodingrnaidentificationandtheirvalidationinpredictingsurvivalofpatientswithmultiplemyeloma
AT zhiyonghuang potentialprognosticlongnoncodingrnaidentificationandtheirvalidationinpredictingsurvivalofpatientswithmultiplemyeloma
AT linzhang potentialprognosticlongnoncodingrnaidentificationandtheirvalidationinpredictingsurvivalofpatientswithmultiplemyeloma
AT jianshen potentialprognosticlongnoncodingrnaidentificationandtheirvalidationinpredictingsurvivalofpatientswithmultiplemyeloma